Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID)
Background
Previous studies assessing the prevalence of COVID-19 sequelae in adults and children were performed in the absence of an agreed definition. We investigated prevalence of post-COVID-19 condition (PCC) (WHO definition), at 6- and 12-months follow-up, amongst previously hospitalised adults and children and assessed risk factors.
Methods
Prospective cohort study of children and adults with confirmed COVID-19 in Moscow, hospitalised between April and August, 2020. Two follow-up telephone interviews, using the International Severe Acute Respiratory and Emerging Infection Consortium survey, were performed at 6 and 12 months after discharge.
Results
One thousand thirteen of 2509 (40%) of adults and 360 of 849 (42%) of children discharged participated in both the 6- and 12-month follow-ups. PCC prevalence was 50% (95% CI 47–53) in adults and 20% (95% CI 16–24) in children at 6 months, with decline to 34% (95% CI 31–37) and 11% (95% CI 8–14), respectively, at 12 months. In adults, female sex was associated with PCC at 6- and 12-month follow-up (OR 2.04, 95% CI 1.57 to 2.65) and (OR 2.04, 1.54 to 2.69), respectively. Pre-existing hypertension (OR 1.42, 1.04 to 1.94) was associated with post-COVID-19 condition at 12 months. In children, neurological comorbidities were associated with PCC both at 6 months (OR 4.38, 1.36 to 15.67) and 12 months (OR 8.96, 2.55 to 34.82) while allergic respiratory diseases were associated at 12 months (OR 2.66, 1.04 to 6.47).
Conclusions
Although prevalence of PCC declined one year after discharge, one in three adults and one in ten children experienced ongoing sequelae. In adults, females and persons with pre-existing hypertension, and in children, persons with neurological comorbidities or allergic respiratory diseases are at higher risk of PCC.
Top-30
Journals
|
1
2
|
|
|
International Journal of Environmental Research and Public Health
2 publications, 2.6%
|
|
|
Frontiers in Immunology
2 publications, 2.6%
|
|
|
EClinicalMedicine
2 publications, 2.6%
|
|
|
Pediatric Pulmonology
2 publications, 2.6%
|
|
|
PLoS ONE
2 publications, 2.6%
|
|
|
BMC Public Health
2 publications, 2.6%
|
|
|
Current Opinion in Pediatrics
1 publication, 1.3%
|
|
|
Journal of the Association of Medical Microbiology and Infectious Disease Canada
1 publication, 1.3%
|
|
|
Diseases
1 publication, 1.3%
|
|
|
SN Comprehensive Clinical Medicine
1 publication, 1.3%
|
|
|
Journal of Infection and Public Health
1 publication, 1.3%
|
|
|
JAMA Internal Medicine
1 publication, 1.3%
|
|
|
International Journal of Infectious Diseases
1 publication, 1.3%
|
|
|
Zeitschrift fur Gesundheitswissenschaften
1 publication, 1.3%
|
|
|
Biology Bulletin Reviews
1 publication, 1.3%
|
|
|
Pediatric Allergy and Immunology
1 publication, 1.3%
|
|
|
American Journal of Epidemiology
1 publication, 1.3%
|
|
|
Clinical and Experimental Dermatology
1 publication, 1.3%
|
|
|
Frontiers in Sociology
1 publication, 1.3%
|
|
|
JMIR Research Protocols
1 publication, 1.3%
|
|
|
Cytokine
1 publication, 1.3%
|
|
|
Pediatrics
1 publication, 1.3%
|
|
|
Molecular Psychiatry
1 publication, 1.3%
|
|
|
European Journal of Internal Medicine
1 publication, 1.3%
|
|
|
Frontiers in Pediatrics
1 publication, 1.3%
|
|
|
Clinical and Experimental Allergy
1 publication, 1.3%
|
|
|
Hypertension Research
1 publication, 1.3%
|
|
|
World Journal of Pediatrics
1 publication, 1.3%
|
|
|
Frontiers in Medicine
1 publication, 1.3%
|
|
|
1
2
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Springer Nature
15 publications, 19.48%
|
|
|
Elsevier
9 publications, 11.69%
|
|
|
Wiley
8 publications, 10.39%
|
|
|
Frontiers Media S.A.
6 publications, 7.79%
|
|
|
Oxford University Press
6 publications, 7.79%
|
|
|
Cold Spring Harbor Laboratory
4 publications, 5.19%
|
|
|
MDPI
3 publications, 3.9%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
2 publications, 2.6%
|
|
|
American Medical Association (AMA)
2 publications, 2.6%
|
|
|
Public Library of Science (PLoS)
2 publications, 2.6%
|
|
|
Taylor & Francis
2 publications, 2.6%
|
|
|
BMJ
2 publications, 2.6%
|
|
|
SAGE
2 publications, 2.6%
|
|
|
University of Toronto Press Inc. (UTPress)
1 publication, 1.3%
|
|
|
Pleiades Publishing
1 publication, 1.3%
|
|
|
JMIR Publications
1 publication, 1.3%
|
|
|
American Academy of Pediatrics
1 publication, 1.3%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 1.3%
|
|
|
Research Square Platform LLC
1 publication, 1.3%
|
|
|
Medknow
1 publication, 1.3%
|
|
|
Media Sphere Publishing House
1 publication, 1.3%
|
|
|
Cambridge University Press
1 publication, 1.3%
|
|
|
Central Research Institute for Epidemiology
1 publication, 1.3%
|
|
|
F1000 Research
1 publication, 1.3%
|
|
|
Scientific Scholar
1 publication, 1.3%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.